Tolfenamic acid inhibits GSK-3β and PP2A mediated tau hyperphosphorylation in Alzheimer’s disease models

[1]  J. Benito-León,et al.  Non-steroidal anti-inflammatory drugs use in older adults decreases risk of Alzheimer’s disease mortality , 2019, PloS one.

[2]  P. Liu,et al.  Prevention of Huntington's Disease-Like Behavioral Deficits in R6/1 Mouse by Tolfenamic Acid Is Associated with Decreases in Mutant Huntingtin and Oxidative Stress , 2019, Oxidative medicine and cellular longevity.

[3]  W. Wani,et al.  Okadaic Acid and Hypoxia Induced Dementia Model of Alzheimer’s Type in Rats , 2019, Neurotoxicity Research.

[4]  D. Koehler,et al.  The GSK3β inhibitor, TDZD-8, rescues cognition in a zebrafish model of okadaic acid-induced Alzheimer's disease , 2019, Neurochemistry International.

[5]  A. Xu,et al.  Exogenous brain-derived neurotrophic factor attenuates cognitive impairment induced by okadaic acid in a rat model of Alzheimer's disease , 2018, Neural regeneration research.

[6]  Melek Öztürk,et al.  Okadaic acid–induced tau hyperphosphorylation and the downregulation of Pin1 expression in primary cortical neurons , 2018, Journal of Chemical Neuroanatomy.

[7]  Dongzhou Ma,et al.  ERα36 gene silencing promotes tau protein phosphorylation, inhibits cell proliferation, and induces apoptosis in human neuroblastoma SH‐SY5Y cells , 2018, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[8]  N. Zawia,et al.  Tolfenamic Acid: A Modifier of the Tau Protein and its Role in Cognition and Tauopathy. , 2018, Current Alzheimer research.

[9]  Wenji He,et al.  Amphetamine Neurotoxicity in PC12 Cells through the PP2A/AKT/GSK3β Pathway , 2018, Neurotoxicity Research.

[10]  Xiong Wang,et al.  Tau-Induced Ca2+/Calmodulin-Dependent Protein Kinase-IV Activation Aggravates Nuclear Tau Hyperphosphorylation , 2017, Neuroscience Bulletin.

[11]  S. Passamonti,et al.  Capsicum annuum var. grossum (Bell Pepper) Inhibits β-Secretase Activity and β-Amyloid1-40 Aggregation. , 2017, Journal of medicinal food.

[12]  V. Sabaratnam,et al.  Edible and Medicinal Mushrooms: Emerging Brain Food for the Mitigation of Neurodegenerative Diseases. , 2017, Journal of medicinal food.

[13]  Jie Xu,et al.  Quercetin Protects against Okadaic Acid-Induced Injury via MAPK and PI3K/Akt/GSK3β Signaling Pathways in HT22 Hippocampal Neurons , 2016, PloS one.

[14]  Raimon Sabaté,et al.  Natural Xanthones from Garcinia mangostana with Multifunctional Activities for the Therapy of Alzheimer’s Disease , 2016, Neurochemical Research.

[15]  A. Alonso,et al.  Abnormal tau induces cognitive impairment through two different mechanisms: synaptic dysfunction and neuronal loss , 2016, Scientific Reports.

[16]  Jing Li,et al.  PP2Acα positively regulates the termination of liver regeneration in mice through the AKT/GSK3β/Cyclin D1 pathway. , 2016, Journal of hepatology.

[17]  Qi Wang,et al.  Morroniside-Induced PP2A Activation Antagonizes Tau Hyperphosphorylation in a Cellular Model of Neurodegeneration. , 2016, Journal of Alzheimer's disease : JAD.

[18]  K. Youn,et al.  Ilex latifolia Prevents Amyloid β Protein (25–35)-Induced Memory Impairment by Inhibiting Apoptosis and Tau Phosphorylation in Mice , 2015 .

[19]  R. Basha,et al.  Tolfenamic acid reduces tau and CDK5 levels: implications for dementia and tauopathies , 2015, Journal of Neurochemistry.

[20]  N. Zawia,et al.  Reduction of amyloid-β deposition and attenuation of memory deficits by tolfenamic acid. , 2014, Journal of Alzheimer's disease : JAD.

[21]  Joo Youn Kim,et al.  Ilex latifolia Prevents Amyloid β Protein (25-35)-Induced Memory Impairment by Inhibiting Apoptosis and Tau Phosphorylation in Mice. , 2015, Journal of medicinal food.

[22]  Qian Xu,et al.  Xanthoceraside rescues learning and memory deficits through attenuating beta-amyloid deposition and tau hyperphosphorylation in APP mice , 2014, Neuroscience Letters.

[23]  N. Zawia,et al.  Tolfenamic acid downregulates BACE1 and protects against lead-induced upregulation of Alzheimer's disease related biomarkers , 2014, Neuropharmacology.

[24]  Lan Zhang,et al.  Cornel Iridoid Glycoside Attenuates Tau Hyperphosphorylation by Inhibition of PP2A Demethylation , 2013, Evidence-based complementary and alternative medicine : eCAM.

[25]  N. Zawia,et al.  Short-term treatment with tolfenamic acid improves cognitive functions in Alzheimer's disease mice , 2013, Neurobiology of Aging.

[26]  P. K. Kamat,et al.  Neuroprotective effect of curcumin on okadaic acid induced memory impairment in mice. , 2013, European journal of pharmacology.

[27]  D. Eslin,et al.  Cellular and Organismal Toxicity of the Anti-Cancer Small Molecule, Tolfenamic Acid: a Pre-Clinical Evaluation , 2013, Cellular Physiology and Biochemistry.

[28]  Peng Liu,et al.  Xanthoceraside attenuates learning and memory deficits via improving insulin signaling in STZ-induced AD rats , 2013, Neuroscience Letters.

[29]  Xia Jiang,et al.  Acetyl‐L‐Carnitine ameliorates spatial memory deficits induced by inhibition of phosphoinositol‐3 kinase and protein kinase C , 2011, Journal of neurochemistry.

[30]  U. Sengupta,et al.  Tau oligomers impair memory and induce synaptic and mitochondrial dysfunction in wild-type mice , 2011, Molecular Neurodegeneration.

[31]  R. Basha,et al.  Tolfenamic acid interrupts the de novo synthesis of the β-amyloid precursor protein and lowers amyloid beta via a transcriptional pathway. , 2011, Current Alzheimer research.

[32]  H. Tanila,et al.  Phosphorylated PP2A (tyrosine 307) is associated with Alzheimer neurofibrillary pathology , 2007, Journal of cellular and molecular medicine.

[33]  M. Leist,et al.  Efficacy of small‐molecule glycogen synthase kinase‐3 inhibitors in the postnatal rat model of tau hyperphosphorylation , 2007, British journal of pharmacology.

[34]  D. Pallas,et al.  Expression of protein phosphatase 2A mutants and silencing of the regulatory Bα subunit induce a selective loss of acetylated and detyrosinated microtubules , 2007, Journal of neurochemistry.

[35]  M. Abdelrahim,et al.  Tolfenamic acid and pancreatic cancer growth, angiogenesis, and Sp protein degradation. , 2006, Journal of the National Cancer Institute.

[36]  Fei Liu,et al.  Contributions of protein phosphatases PP1, PP2A, PP2B and PP5 to the regulation of tau phosphorylation , 2005, The European journal of neuroscience.

[37]  G. Johnson,et al.  Tau phosphorylation in neuronal cell function and dysfunction , 2004, Journal of Cell Science.

[38]  Hilde van der Togt,et al.  Publisher's Note , 2003, J. Netw. Comput. Appl..

[39]  Takashi Morihara,et al.  Selective inhibition of Aβ42 production by NSAID R‐enantiomers , 2002 .

[40]  G. Cole,et al.  Selective inhibition of Abeta42 production by NSAID R-enantiomers. , 2002, Journal of neurochemistry.

[41]  K. Ashe,et al.  Ibuprofen Suppresses Plaque Pathology and Inflammation in a Mouse Model for Alzheimer's Disease , 2000, The Journal of Neuroscience.

[42]  K. Ishiguro,et al.  Distribution of tau protein kinase I/glycogen synthase kinase-3β, phosphatases 2A and 2B, and phosphorylated tau in the developing rat brain , 2000, Brain Research.

[43]  J. Brion,et al.  Developmental expression and localization of glycogen synthase kinase-3β in rat brain , 1999, Journal of Chemical Neuroanatomy.